Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

59 studies match

clinicaltrialsPublishedShowing 1–50 of 59 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00097981	A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma	completed	Phase 3	225	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY	1	Apr 7, 2017	clinicaltrials
NCT01217697	Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer	approved for marketing	—	—	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.